Macedonian Journal of Medical Sciences
[International Peer Reviewed]

 

About MJMS

Our policies

MJMS Online

For contributors

Services

Why publish in MJMS?
Editors
Boards
Indexing
Membership
Evaluation

Editorial & publishing policies
Competing interests policy 
Open access
Open access license

Publication fee
Reviewer guidelines

Online first
Current issue
Journal archive

Online first fact sheet
Free Registration
Contact

Guidelines  [pdf]
ICMJE Disclosure Form
Online submission
Help for authors
Cover letter
Reviewers of MJMS

Transliteration
Subscriptions

Advertising
Reprints and permissions
Resources

 

Macedonian Journal of Medical Sciences. 2011 Mar 15; 4(1):12-16.

doi:10.3889/MJMS.1857-5773.2011.0146

Basic Science

 

RADAR Calculated vs. TLD Effective Doses to Family Members of Thyroid Cancer Patients Treated with Iodine 131
 

Marina Zdraveska-Kocovska, Olivija Vaskova, Venjamin Majstorov

Institute of Pathophysiology and Nuclear Medicine “Akademik Isak S. Tadzer” - Faculty of Medicine, University “Ss. Kiril and Metodij”, Skopje, Republic of Macedonia

 

Abstract

 

 

Introduction: Patients who receive therapeutic amount of radioactive iodine 131 are significant sources of radiation to their family members, members of the public and others. The situation can be overcome by imposing restrictions on the behavior of the patient to minimize the effective dose to close relatives and not to exceed the proposed dose limits by the International Commission of Radiation Protection (ICRP) and Basic Safety Standards (BSS) from the International Atomic Energy Agency (IAEA).

Aim: The aim of this study was to evaluate effective dose to family members of thyroid cancer patients treated with radioiodine 131.

Material and Methods: We used thermoluminiscent dosimeters (TLD 100) and RADAR (Radiation Dose Assessment Resource) software for estimation of effective doses.

Results: The mean value of effective dose to relatives of thyroid cancer patients was 0.21 mSv. The estimated value of RADAR calculated effective doses for the distance of 0.25, 0.5 m, 1.0 m, 2.0 m were 17 mSv, 4.20 mSv, 1.00 mSv and 0.26 mSv respectively for administered activity of 3700 MBq.

Conclusion: Thyroid cancer patients should continue to be treated on in – patient basis to be sure that they will represent minimal radiation hazard for the people in their environment.

..................

Citation: Zdraveska-Kocovska M, Vaskova O, Majstorov V. RADAR Calculated vs. TLD Effective Doses to Family Members of Thyroid Cancer Patients Treated with Iodine 131. Maced J Med Sci. 2011 Mar 15; 4(1):12-16. doi.10.3889/MJMS.1957-5773.2011.0146.

Key words: thyroid cancer; relatives; radioiodine; TLD; RADAR software.

Correspondence: Marina Zdraveska Kocovska, medical physicist. Institute of Pathophysiology and Nuclear Medicine, Medical Faculty, Vodnjanska 17, 1000 Skopje, Republic of Macedonia. Phone: + 389 23 11 28 31; Fax: + 389 23 14 72 03; Mobile: + 389 71 21 35 73. E-mail: mzk2003@hotmail.com

Received: 25-Jun-2010; Revised: 29-Aug-2010; Accepted: 15-Sep-2010; Online first: 18-Jan-2011

Copyright: © 2011 Zdraveska-Kocovska M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Competing Interests: The author have declared that no competing interests exist.

 

< Previous | Next Article >

Table of contents

 

This Article (free)

Abstract

Macedonian Abstract

Full text (html)

Full text (pdf)

Full text OnlineFirst (pdf)

Citations

- DOAJ

- Index Copernicus

- Socol@ar

Google Scholar

- Zdravevska-Kocovska M

- Vaskova O

- Majstorov V

PubMed

- Zdravevska-Kocovska M

- Vaskova O

- Majstorov V


Publication of the MJMS is supported by the Macedonian Ministry of Education and Sciences. Publisher: Institute of Immunobiology and Human GeneticsSkopje, Republic of Macedonia.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.

MJMS Print (ISSN 1857-5749) is an international peer-reviewed, Open Access journal published four times per year. MJMS Online (ISSN 1857-5773) offers free access to all articles.


Creative Commons Attribution LicenseAll site content, except where otherwise noted, is licensed under a Creative Commons Attribution License.